Dr. Pant is affiliated with Green Bay, Wis.-based Prevea Health, where he performed a procedure using WATS3D, a diagnostics platform that includes a specially designed brush instrument to collect tissues in the esophagus and below the surface.
According to Prevea’s website, samples are sent to laboratories, where artificial intelligence is used to more accurately detect precancerous cells.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
